Search results for "abdominal"

showing 10 items of 886 documents

Videolaparoscopic cholecystectomy in patients with previous abdominal surgery. Personal experience and literature review

2017

Objectives. Laparoscopic cholecystectomy (LC) is today the "gold standard" treatment of gallbladder stones. Role of LC is still debated in the presence of abdominal scars due to the frequent post-operative adhesions which make access to the peritoneal cavity difficult. This study aim to assess role and outcomes of LC on a previous abdominal surgery on the scarred abdomen. Materials and Methods. we have carried out a retrospective study on 499 consecutive patients who had undergone LC from 2009 to 2015; 21 of these (4.2%) undergone previous abdominal surgery. In all 21 cases the pneumoperitoneum was established with Veress needle at the Palmer's point and the procedure was carried out after …

AdultAged 80 and overMaleReoperationMedicine (all)Tissue AdhesionsMiddle AgedCicatrixYoung AdultPostoperative ComplicationsPrevious abdominal surgeryCholecystectomy LaparoscopicCholelithiasisAbdomenAdhesionFeasibility StudiesHumansFemaleCholecystectomyLaparoscopyAdhesions; Cholecystectomy; Laparoscopy; Previous abdominal surgery; Medicine (all)AgedRetrospective Studies
researchProduct

Homocysteine levels in morbidly obese patients: its association with waist circumference and insulin resistance.

2012

The association between morbid obesity and hyperhomocysteinemia (HH) remains controversial and the nature of this relationship needs to be clarified as several metabolic, lipidic, inflammatory and anthropometric alterations that accompany morbid obesity may be involved. In 66 morbidly obese patients, 47 women and 19 men aged 41 ± 12 years and 66 normo-weight subjects, 43 women and 23 men, aged 45 ± 11 years, we determined homocysteine (Hcy) levels along with lipidic, anthropometric, inflammatory and insulin resistance markers. In addition, we investigated the effect of Metabolic Syndrome (MS) and its components on Hcy levels. Obese patients had statistically higher Hcy levels than controls:…

AdultBlood GlucoseLeptinMaleHyperhomocysteinemiamedicine.medical_specialtyWaistHomocysteinePhysiologymedicine.medical_treatmentHyperhomocysteinemiachemistry.chemical_compoundInsulin resistancePhysiology (medical)Internal medicinemedicineHumansHomocysteineAbdominal obesityMetabolic Syndromebusiness.industryInsulinLeptinHematologyMiddle Agedmedicine.diseaseObesity MorbidEndocrinologychemistryObesity AbdominalFemalemedicine.symptomMetabolic syndromeInsulin ResistanceWaist CircumferenceCardiology and Cardiovascular MedicinebusinessClinical hemorheology and microcirculation
researchProduct

Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome

2007

Objective To assess message expression of adiponectin and leptin in visceral and SC fat in women with polycystic ovary syndrome (PCOS) and in control women. Design Prospective clinical trial. Setting Academic medical centers in Mexico City, Mexico and New York, New York. Patient(s) Women with PCOS and control women. Intervention(s) Surgical biopsies of visceral (omental) and subcutaneous (SC) adipose tissue, fasting blood samples, and ultrasound measurements of visceral and SC fat. Main Outcome Measure(s) Messenger RNA assessment of adiponectin and leptin in adipose tissue samples; serum measurements of adiponectin, leptin, glucose, insulin, and hormone levels; measurements of fat quantity …

AdultBlood GlucoseLeptinmedicine.medical_specialtymedicine.medical_treatmentAbdominal FatNew YorkSubcutaneous FatAdipokineAdipose tissueBody Mass IndexSettore MED/13 - EndocrinologiaInsulin resistanceInternal medicineAbdominal fat adiponectin leptin polycystic ovary syndrome insulin resistancemedicineHumansInsulinProspective StudiesRNA MessengerMexicoUltrasonographyAdiponectinbusiness.industryLeptinInsulinnutritional and metabolic diseasesObstetrics and Gynecologymedicine.diseasePolycystic ovaryEndocrinologyReproductive MedicineCase-Control StudiesFemaleAdiponectinInsulin ResistancebusinessBody mass indexhormones hormone substitutes and hormone antagonistsPolycystic Ovary Syndrome
researchProduct

Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1.

2010

Metabolic factors have been associated with liver damage in patients with genotype 1 chronic hepatitis C (G1 CHC). We tested visceral adiposity index (VAI), a new marker of adipose dysfunction in G1 CHC, patients to assess its association with host and viral factors and its link to both histological findings and sustained virological response (SVR). Two hundred thirtysix consecutive G1 CHC patients were evaluated by way of liver biopsy and anthropometric and metabolic measurements, including insulin resistance (IR), homeostasis model assessment (HOMA), and VAI using waist circumference, body mass index, triglycerides, and highdensity lipoprotein cholesterol. All biopsies were scored by one …

AdultBlood GlucoseMalemedicine.medical_specialtyPathologyAlcohol DrinkingGenotypeInterferon alpha-2Intra-Abdominal FatGastroenterologyAntiviral AgentsBody Mass IndexPolyethylene GlycolsInsulin resistanceInternal medicineDiabetes mellitusmedicineHumansHepatologymedicine.diagnostic_testbusiness.industryCholesterol HDLInterferon-alphaAlanine TransaminaseHepatitis CHepatologyHepatitis C ChronicMiddle AgedViral Loadmedicine.diseaseRecombinant ProteinsFatty LiverDiabetes Mellitus Type 2Liver biopsyHypertensionRNA ViralFemaleSteatosisWaist CircumferencebusinessViral loadBody mass indexHepatology (Baltimore, Md.)
researchProduct

The Metabolic Profile in Active Acromegaly is Gender-Specific.

2012

CONTEXT: The sexual dimorphism of the somatotroph axis has been documented, but whether the acromegaly-related metabolic alterations are gender-dependent has never been investigated. OBJECTIVE: The aim of the study was to evaluate the impact of gender on the metabolic parameters in acromegaly. DESIGN: We conducted a retrospective, comparative, multicenter study. PATIENTS: The 307 newly diagnosed acromegalic patients included in the study were grouped by gender: 157 men (aged 48.01 ± 14.28 yr), and 150 women (aged 48.67 ± 14.95 yr; of which 77 were premenopausal and 73 postmenopausal). OUTCOME MEASUREMENTS: We measured each component of the metabolic syndrome (MS), hemoglobin A1c, the areas …

AdultBlood GlucoseMalemedicine.medical_specialtySomatotropic cellEndocrinology Diabetes and Metabolismmedicine.medical_treatmentClinical BiochemistryContext (language use)Intra-Abdominal FatBiochemistrySettore MED/13 - EndocrinologiaCohort StudiesEndocrinologyInsulin resistanceInternal medicineAcromegalygendermedicineHumansInsulinAgedRetrospective StudiesSex Characteristicsbusiness.industryInsulinBiochemistry (medical)FastingMiddle Agedmedicine.diseasemetabolic profileObesitySexual dimorphismEndocrinologyAcromegalyMetabolomeFemaleMetabolic syndromeInsulin Resistancebusiness
researchProduct

Visceral adiposity index and DHEAS are useful markers of diabetes risk in women with polycystic ovary syndrome

2014

ObjectiveOn the basis of the known diabetes risk in polycystic ovary syndrome (PCOS), recent guidelines of the Endocrine Society recommend the use of an oral glucose tolerance test (OGTT) to screen for impaired glucose tolerance (IGT) and type 2 diabetes (T2DM) in all women with PCOS. However, given the high prevalence of PCOS, OGTT would have a high cost–benefit ratio. In this study, we identified, through a receiver operating characteristic analysis, simple predictive markers of the composite endpoint (impaired fasting glucose (IFG) or IGT or IFG+IGT or T2DM) in women with PCOS according to the Rotterdam criteria.DesignWe conducted a cross-sectional study of 241 women with PCOS in a unive…

AdultBlood Glucosemedicine.medical_specialtyDiabetes riskWaistendocrine system diseasesAdolescentEndocrinology Diabetes and MetabolismType 2 diabetesIntra-Abdominal FatSettore MED/13 - EndocrinologiaImpaired glucose toleranceYoung AdultInsulin resistanceEndocrinologyAdiposity; Adolescent; Adult; Biological Markers; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus Type 2; Female; Humans; Intra-Abdominal Fat; Polycystic Ovary Syndrome; Risk Factors; Young Adult; Endocrinology; Endocrinology Diabetes and Metabolism; Medicine (all)Risk FactorsInternal medicineDiabetes mellitusmedicineHumansAdiposityCross-Sectional Studiebusiness.industryRisk FactorMedicine (all)nutritional and metabolic diseasesGeneral MedicineImpaired fasting glucosemedicine.diseasePolycystic ovaryCross-Sectional StudiesEndocrinologyDiabetes Mellitus Type 2Biological MarkerFemalebusinessBiomarkersHumanPolycystic Ovary Syndrome
researchProduct

Giant pseudocyst of the abdominal wall following incisional ventral hernia repair: an extremely rare clinical entity. Report of a case

2021

Il “gold standard” per il trattamento dei laparoceli è l’intervento chirurgico con impiego di protesi, nonostante questo approccio sia gravato da numerose complicanze post-operatorie; tra queste possiamo annoverare le pseudocisti giganti della parete addominale, tale evenienza risulta ancora molto rara e la sua eziopatogenesi riamane non chiara. In questo lavoro descriviamo il caso clinico di una paziente di 36 anni, diabetica ed obesa, precedentemente sottoposta a taglio cesareo e riparazione di laparocele con posizionamento di protesi in sede soprafasciale. La paziente si è presentata presso i nostri ambulatori per la comparsa di un gonfiore asintomatico a livello della fossa iliaca sinis…

AdultCystsRecurrenceAbdominal WallDiabetes MellitusHumansIncisional HerniaFemaleObesitySurgical MeshAbdominal Wall pathology Adult Cysts* / pathology Diabetes Mellitus Female Hernia Ventral* / surgeryHernia VentralHerniorrhaphy
researchProduct

Imaging of urinary bladder hernias

2005

Lorenzo E. Bacigalupo1, Michele Bertolotto2, Filippo Barbiera3, Pietro Pavlica4, Roberto Lagalla3, Roberto S. Pozzi Mucelli2, Lorenzo E. Derchi1 Bacigalupo LE, Bertolotte M, Barbiera F, et al. erniation of the urinary bladder is not rare. It is usually considered that 1–3% of all inguinal hernias involve the bladder [1], and Iason [2], in 1944, reported an incidence of 10% in men older than 50 years. Most bladder hernias involve the inguinal and femoral canals, with the latter more frequent in women, and a predilection for the right side has been reported. However, herniations through ischiorectal, obturator, and abdominal wall openings have also been described. Any portion of the bladder m…

AdultDiagnostic ImagingMalemedicine.medical_specialtyHerniaPerforation (oil well)Urologyurologic and male genital diseasesAbdominal wallDiagnosis Differentialurinary bladder herniasScrotummedicineHumansRadiology Nuclear Medicine and imagingHerniaProstatismAgedUrinary bladderbusiness.industryradioiologyUrinary bladder; Urinary bladder hernias; PeritoneumUrinary Bladder DiseasesimagingGeneral MedicineMiddle Agedmedicine.diseaseFemoral herniafemale genital diseases and pregnancy complicationsUrinary bladderradioiology; imaging; urinary bladder herniasSurgeryNeck of urinary bladdermedicine.anatomical_structureFemalePeritoneumbusiness
researchProduct

Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema

2005

BACKGROUND: Abdominal edema attacks in patients with hereditary angioedema are often extremely painful, associated with vomiting and diarrhea, and have a high potential for causing recurrent disability of the patient. STUDY DESIGN AND METHODS: Intraindividual comparison of retrospective data in 75 hereditary angioedema patients comprising 4,834 abdominal attacks treated with C1 inhibitor concentrate versus 17,444 untreated abdominal attacks. RESULTS: The mean duration of abdominal attacks was 92.0 hours (SD, 40.8 hr) when untreated compared to 39.9 hours (SD, 30.0 hr) when treated. Patients reported a mean maximal pain score of 8.6 (SD, 1.7; range, 1-10) for untreated attacks compared to 4.…

AdultDiarrheaAbdominal painTime FactorsAdolescentVomitingHypovolemiaImmunologyUnconsciousnessComplement C1 Inactivator ProteinsDrug Administration ScheduleInjectionsC1-inhibitorEcallantideHypovolemiaEdemamedicineHumansImmunology and AllergyAngioedemaChildAdverse effectSerpinsRetrospective StudiesDose-Response Relationship Drugbiologybusiness.industryInfantHematologymedicine.diseaseAbdominal PainTreatment OutcomePatient SatisfactionChild PreschoolAnesthesiaHereditary angioedemaVomitingbiology.proteinmedicine.symptombusinessComplement C1 Inhibitor ProteinBed Restmedicine.drugTransfusion
researchProduct

Prospective multicenter trial of capsule endoscopy in patients with chronic abdominal pain, diarrhea and other signs and symptoms (CEDAP-Plus Study)

2007

Background On the basis of the published data, capsule endoscopy cannot be recommended in patients whose only symptom is chronic abdominal pain. The present study therefore focused on the diagnostic yield of capsule endoscopy in patients with chronic abdominal pain who were also suffering from additional symptoms. Patients and methods A total of 50 patients with chronic abdominal pain, plus other symptoms singly or in combination were enrolled in this prospective multicenter trial. The "plus" symptoms or signs consisted of weight loss (> 10 % of body weight), inflammation shown by laboratory tests, chronic anemia, or suspected mid-gastrointestinal bleeding. Chronic diarrhea was recorded if …

AdultDiarrheaMaleEnteroscopymedicine.medical_specialtyGastrointestinal bleedingAdolescentAnemiaBiopsyAdenocarcinomaCapsule EndoscopyGastroenterologylaw.inventionDiagnosis DifferentialCrohn DiseaseCapsule endoscopylawInternal medicineMulticenter trialIntestinal NeoplasmsOdds RatiomedicineHumansProspective StudiesProspective cohort studyAgedbusiness.industryGastroenterologyEquipment DesignOdds ratioMiddle AgedPrognosismedicine.diseaseAbdominal PainCeliac Diseasemedicine.anatomical_structureCapsule EndoscopesChronic DiseaseAbdomenFemalebusinessFollow-Up StudiesEndoscopy
researchProduct